Free Trial

Oscar Health (OSCR) Stock Forecast & Price Target

$15.59
+0.25 (+1.63%)
(As of 05:23 PM ET)

Oscar Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 9 Wall Street analysts who have issued ratings for Oscar Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 9 analysts, 3 have given a hold rating, 5 have given a buy rating, and 1 has given a strong buy rating for OSCR.

Consensus Price Target

$19.75
26.68% Upside
High Forecast$28.00
Average Forecast$19.75
Low Forecast$7.50

According to the 9 analysts' twelve-month price targets for Oscar Health, the average price target is $19.75. The highest price target for OSCR is $28.00, while the lowest price target for OSCR is $7.50. The average price target represents a forecasted upside of 26.68% from the current price of $15.59.

TypeCurrent Forecast
7/24/23 to 7/23/24
1 Month Ago
6/24/23 to 6/23/24
3 Months Ago
4/25/23 to 4/24/24
1 Year Ago
7/24/22 to 7/24/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
2 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$19.75$19.00$13.50$5.39
Forecasted Upside26.68% Upside21.74% Upside18.24% Upside0.60% Upside
Get Oscar Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OSCR and its competitors with MarketBeat's FREE daily newsletter.

OSCR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OSCR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Oscar Health Stock vs. The Competition

TypeOscar HealthFinance CompaniesS&P 500
Consensus Rating Score
2.78
2.45
2.51
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside25.88% Upside36.54% Upside9.59% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/10/2024Piper Sandler
2 of 5 stars
 Reiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.00+53.66%
6/12/2024Wells Fargo & Company
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$24.00 ➝ $27.00+34.90%
5/30/2024Baird R W
0 of 5 stars
M. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/30/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$28.00+38.75%
5/30/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Neutral$25.00 ➝ $21.00+4.06%
5/9/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$16.00 ➝ $21.00+1.20%
3/22/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$20.00+45.40%
8/30/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$5.00 ➝ $7.50+17.55%
8/9/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$7.00 ➝ $8.50+6.38%
2/14/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$3.00 ➝ $6.00+13.42%
11/16/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$3.00+0.67%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 05:44 PM ET.

OSCR Forecast - Frequently Asked Questions

What is Oscar Health's forecast for 2024?

According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Oscar Health is $19.75, with a high forecast of $28.00 and a low forecast of $7.50.

Should I buy or sell Oscar Health stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oscar Health in the last twelve months. There are currently 3 hold ratings, 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" OSCR shares.

Does Oscar Health's stock price have much upside?

According to analysts, Oscar Health's stock has a predicted upside of 25.88% based on their 12-month stock forecasts.

Has Oscar Health been upgraded by Wall Street analysts recently?

Over the previous 90 days, Oscar Health's stock had 1 upgrade by analysts.

What analysts cover Oscar Health?

Oscar Health has been rated by research analysts at Baird R W, Bank of America, Piper Sandler, Robert W. Baird, The Goldman Sachs Group, and Wells Fargo & Company in the past 90 days.

Do Wall Street analysts like Oscar Health more than its competitors?

Analysts like Oscar Health more than other "finance" companies. The consensus rating for Oscar Health is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how OSCR compares to other companies.


This page (NYSE:OSCR) was last updated on 7/23/2024 by MarketBeat.com Staff

From Our Partners